News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ajinomoto and Eisai Company, Ltd. (ESALY.PK) Release: A Once-weekly Antiosteoporotic Agent 'Actonel(R) 17.5 mg Tablets' is Launched



6/19/2007 1:12:16 PM

Tokyo, June 15, 2007 (JCN Newswire) - Ajinomoto Co., Inc. and Eisai Co., Ltd. launched today a once-weekly antiosteoporotic agent 'Actonel(R) 17.5 mg tablets' - generic name: risedronate sodium hydrate - which was included in the NHI price list on June 8, 2007. Ajinomoto owns the drug manufacturing approval of above product, and Eisai distributes the product supplied by Ajinomoto.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES